Schramm K, Krause K, Bittroff-Leben A, Goldin-Lang P, Thiel E, Kreuser E D
Department of Hematology and Oncology, University Medical Center Benjamin Franklin, Free University, Berlin, Germany.
Int J Cancer. 2000 Jul 15;87(2):155-64. doi: 10.1002/1097-0215(20000715)87:2<155::aid-ijc1>3.0.co;2-j.
Integrins participate in controlling proliferation and migration. Therefore, changes in integrin expression might be responsible for unrestrained proliferation and invasiveness of tumor cells. Alterations of integrin subunit expression have been observed in human colon carcinoma, especially loss or reduction of the alpha5 subunit, which was observed consistently. The mechanisms responsible for reduction of alpha5 expression and alteration of expression of other integrins are not fully understood. Circumstantial evidence from previous investigations points to an involvement of activated ras oncogenes in repression of integrin expression. The K-ras protooncogene is activated by point mutation in 50% of human colon carcinomas. Thus, we choose an antisense approach for specific inactivation of activated K-ras in the human colon carcinoma cell line SW 480 in order to test whether activated K-ras contributes to changes in integrin expression on colon carcinoma cells. Cell surface expression of the alpha1 and the alpha5 subunit was increased in K-ras antisense transfected clones, cell surface expression of the alpha3 subunit and the alphav subunit was decreased. This shows, in a human system, that activated K-ras is involved in diminishing cell surface expression of the alpha1beta1 collagen/laminin receptor and the alpha5beta1 fibronectin receptor, both of which are implicated in maintenance of a non-transformed phenotype. Moreover, activated K-ras contributes to increased cell surface expression of the alpha3beta1 laminin/collagen/fibronectin receptor and the alphavbeta5 vitronectin receptor, which might play a role in metastatic behavior of tumor cells.
整合素参与控制细胞增殖和迁移。因此,整合素表达的变化可能是肿瘤细胞不受控制的增殖和侵袭性的原因。在人类结肠癌中已观察到整合素亚基表达的改变,尤其是α5亚基的缺失或减少,这种情况一直存在。导致α5表达减少和其他整合素表达改变的机制尚未完全了解。先前研究的间接证据表明,激活的ras癌基因参与了整合素表达的抑制。在50%的人类结肠癌中,K-ras原癌基因通过点突变被激活。因此,我们选择一种反义方法来特异性灭活人类结肠癌细胞系SW 480中激活的K-ras,以测试激活的K-ras是否导致结肠癌细胞整合素表达的变化。在转染了K-ras反义基因的克隆中,α1和α5亚基的细胞表面表达增加,α3亚基和αv亚基的细胞表面表达减少。这表明,在人类系统中,激活的K-ras参与减少α1β1胶原/层粘连蛋白受体和α5β1纤连蛋白受体的细胞表面表达,这两种受体都与维持未转化表型有关。此外,激活的K-ras有助于增加α3β1层粘连蛋白/胶原/纤连蛋白受体和αvβ5玻连蛋白受体的细胞表面表达,这可能在肿瘤细胞的转移行为中起作用。